Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Marijuana Abuse × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 1432 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1119 Lymphoma, Non-Hodgkin 1081 Leukemia, Lymphocytic, Chronic, B-Cell 961 Lymphoma, Follicular 857 Lymphoma, Large B-Cell, Diffuse 746 Leukemia 708 Hodgkin Disease 690 Lymphoma, Mantle-Cell 598 Leukemia, Myeloid, Acute 466 Burkitt Lymphoma 445 Multiple Myeloma 426 Lymphoma, B-Cell, Marginal Zone 419 Myelodysplastic Syndromes 324 Lymphoma, Large-Cell, Immunoblastic 323 Recurrence 312 Lymphoma, T-Cell, Cutaneous 281 Neoplasms 267 Waldenstrom Macroglobulinemia 265 Mycosis Fungoides 223 Lymphoma, Large-Cell, Anaplastic 222 Sezary Syndrome 203 Lymphoma, B-Cell 200 Blast Crisis 184 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 180 Myeloproliferative Disorders 177 Neoplasms, Plasma Cell 163 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 162 Leukemia, Myeloid, Accelerated Phase 159 Leukemia, Myeloid, Chronic-Phase 153

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04923230 2023-09-26

CAP

Oregon Research Institute

Phase NA Completed

Marijuana Abuse, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡